Synthesis of Iron-Based Nanoparticles for Cancer Treatment: Conventional and Green Approaches, Surface Functionalization, Therapeutic Mechanisms, and Future Perspectives
Cancer remains one of the leading causes of mortality worldwide, creating an urgent demand for innovative therapeutic approaches capable of improving treatment efficacy while minimizing adverse effects on healthy tissues. Iron-based nanoparticles, particularly iron oxide nanoparticles (IONPs), have emerged as promising nanotherapeutic platforms because of their distinctive magnetic properties, tunable physicochemical characteristics, relatively favorable biocompatibility, and potential for surface functionalization. Considerable research has focused on developing efficient synthesis strategies to produce nanoparticles with controlled particle size, morphology, crystallinity, magnetic properties, and surface chemistry. This review comprehensively discusses conventional and emerging approaches for synthesizing iron-based nanoparticles, including chemical co-precipitation, thermal decomposition, hydrothermal and solvothermal processing, sol–gel synthesis, microemulsion, sonochemical methods, and green and biological synthesis. Particular attention is given to the influence of synthesis parameters on nanoparticle characteristics and their subsequent biological performance. Furthermore, surface modification strategies involving polymers, silica, lipids, targeting ligands, and biomolecules are examined to improve colloidal stability, drug-loading capacity, tumor accumulation, and therapeutic selectivity. The major cancer-treatment applications of these nanomaterials, including magnetic hyperthermia, targeted chemotherapy, chemodynamic therapy, photothermal therapy, radiotherapy enhancement, and combination therapies, are critically evaluated. The underlying therapeutic mechanisms, including magnetic-field-induced heating, iron-mediated reactive oxygen species generation, and ferroptosis induction, are also discussed. Finally, the principal challenges associated with toxicity, biodistribution, biodegradation, manufacturing reproducibility, and clinical translation are highlighted. This review provides an integrated understanding of the relationship between synthesis, physicochemical properties, biological interactions, and therapeutic performance, offering perspectives for developing safer and more effective iron-based nanoplatforms for cancer treatment.
Authors
- Weikaixin Kong (ORCID: https://orcid.org/0000-0002-1070-7136)
- Hao Sun (ORCID: https://orcid.org/0000-0002-6483-7606)
- Yuanyin Teng (ORCID: https://orcid.org/0009-0003-5331-7220)
- Xinling Li
- Keyang Xu
- Weichu Tang
Institutions
- Macau University of Science and Technology (MO)
- Georgia Institute of Technology (US)
- Emory University (US)
- King's College London (GB)
- The Wallace H. Coulter Department of Biomedical Engineering (US)
- King's College School (GB)
- University College London (GB)
- Zhejiang University (CN)
- Aalto University (FI)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24333051
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00